Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target? (2019)
Attributed to:
Smart Therapeutics for High Blood Pressure
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ajh/hpz091
PubMed Identifier: 31145445
Publication URI: http://europepmc.org/abstract/MED/31145445
Type: Journal Article/Review
Volume: 32
Parent Publication: American journal of hypertension
Issue: 9
ISSN: 0895-7061